This new report provides analysis of Ceva’s capabilities, goals and strategies in the global animal health market, including:

- Sales, growth and R&D investment
- Biomune, Phylaxia and French sites
- 2016 acquisitions
- Hatcher automation and in-ovo vaccination
- India acquisition
- Brazil--important strategic market
- Merial swine vaccines acquisition

The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includes five-year forecasts for:

- Major market segments
- Key geographic regions